PyInvesting

Market research

6600.HK SciClone Pharmaceuticals (Holdings) Limited

HK HKD Technology

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
10B
P/E ratio
Not available
Analyst target
83.9714
Dividend yield
Not available
Beta
Not available

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

From a valuation standpoint, the stock is 95.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.

Based on the above factors, Sciclone Pharms (Hldg) Ltd gets an overall score of 1/5.